Spaulding Medical CEO, Amanda Baltz, is getting ready to showcase what the Menomonee Falls based MedTech company has been working on behind closed doors.

“The last couple of years we’ve been heads-down, developing our next-gen product and we are so excited about what we’ve developed to help our clients,” Baltz said. “We are in the final days of waiting for our 510(k) FDA approval.”

The company will soon release a new version of the remote cardiac monitor that made headlines when it was released in 2011 by Spaulding Clinical, and created so much demand that it resulted in the spun off company, Spaulding Medical. Baltz anticipates customers will embrace the robustly enhanced product.

Click here to read the full article.